MARKET

AVGR

AVGR

Avinger
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.3496
+0.0046
+1.33%
Pre Market: 0.3292 -0.0204 -5.84% 08:12 09/21 EDT
OPEN
0.3500
PREV CLOSE
0.3450
HIGH
0.3551
LOW
0.3373
VOLUME
4.82M
TURNOVER
--
52 WEEK HIGH
1.630
52 WEEK LOW
0.2411
MARKET CAP
29.21M
P/E (TTM)
-0.1815
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Neurocrine Presents Data, And Other News: The Good, Bad And Ugly Of Biopharma
Neurocrine presents encouraging three-year data for Parkinson’s treatment.Avinger receives FDA approval for Ocelaris.Editas bounces on favorable CRISPR patent ruling.
Seekingalpha · 2d ago
ROCE Insights For Avinger
Benzinga · 09/11 15:26
Avinger Receives FDA Clearance of Ocelaris Next Generation Image-guided CTO Crossing System
Innovative New Product to be Marketed under TIGEREYE™ Brand NameREDWOOD CITY, CA / ACCESSWIRE / September 11, 2020 / Avinger, Inc.
ACCESSWIRE · 09/11 12:30
Aegis Capital Corp. acted as Sole Bookrunner on a $5.2 Million Follow-On Offering for Avinger Inc. (NASDAQ: AVGR)
NEW YORK, NY / ACCESSWIRE / August 31, 2020 / Aegis Capital Corp.
ACCESSWIRE · 08/31 15:50
Mid-Afternoon Market Update: Dow Jumps 150 Points; Cato Shares Plummet
Toward the end of trading Friday, the Dow traded up 0.55% to 27892.13 while the NASDAQ rose 0.29% to 11298.02. The S&P also rose, gaining 0.23% to 3,393.30.
Benzinga · 08/21 18:43
Looking Into Avinger's Return On Capital Employed
During Q2, Avinger (NASDAQ: AVGR) brought in sales totaling $1.50 million. However, earnings decreased 34.44%, resulting in a loss of $3.59 million. In Q1, Avinger brought in $2.26 million in sales but lost $5.48 million in earnings.Why ROCE Is Significant Changes in earnings and sales indicate shifts
Benzinga · 08/21 15:55
Avinger Priced 11.06M Share Public Offering of Common Stock @$0.47/Share
Avinger, Inc. (NASDAQ: AVGR) announced the pricing of an underwritten public offering with gross proceeds to the Company expected to be approximately $5.2 million before deducting underwriting discounts and commissions and other estimated offering expenses pay
Benzinga · 08/21 10:09
Avinger prices $5.2 million underwritten public offering of common stock
Avinger (AVGR) has priced its public offering of 11,063,830 common shares at a discounted price of $0.47/share, from yesterday's close of $0.61, for gross proceeds of ~$5.2M. Net proceeds will
Seekingalpha · 08/21 04:32
More
Forecast
EPSBVPSCFPS
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AVGR stock price target is 1.000 with a high estimate of 1.000 and a low estimate of 1.000.
EPS
Institutional Holdings
Institutions: 39
Institutional Holdings: 4.73M
% Owned: 5.66%
Shares Outstanding: 83.56M
TypeInstitutionsShares
Increased
6
2.02M
New
12
347.32K
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.87%
Healthcare Equipment & Supplies
-0.40%
Key Executives
Chairman/Independent Director
James Cullen
President/Chief Executive Officer/Director
Jeffrey Soinski
Chief Financial Officer
Mark Weinswig
Chief Technology Officer
Himanshu Patel
Other
Jaafer Golzar
Director
Tamara Elias
Independent Director
Donald Lucas
Independent Director
James McElwee
  • Dividends
  • Splits
  • Insider Activity
No Data

Analyst Price Target

The average AVGR stock price target is 1.000 with a high estimate of 1.000 and a low estimate of 1.000.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About AVGR
Avinger, Inc., (Avinger) is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with the peripheral arterial disease (PAD). The Company manufactures and sells a suite of products in the United States and select international markets. Avinger’s products include its Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Avinger Inc stock information, including NASDAQ:AVGR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVGR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AVGR stock methods without spending real money on the virtual paper trading platform.